KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teladoc Health (TDOC) Non Operating Income (2020 - 2026)

Teladoc Health's Non Operating Income history spans 7 years, with the latest figure at -$196000.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 108.05% to -$196000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $7.7 million, a 339.57% increase, with the full-year FY2025 number at $10.4 million, up 271.81% from a year prior.
  • Non Operating Income hit -$196000.0 in Q1 2026 for Teladoc Health, down from $378000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for TDOC hit a ceiling of $8.4 million in Q2 2025 and a floor of -$7.3 million in Q4 2024.
  • Historically, Non Operating Income has averaged $454352.9 across 5 years, with a median of -$196000.0 in 2026.
  • Biggest five-year swings in Non Operating Income: tumbled 911.06% in 2022 and later surged 1586.86% in 2025.
  • Tracing TDOC's Non Operating Income over 5 years: stood at $1.7 million in 2022, then decreased by 12.07% to $1.5 million in 2023, then crashed by 577.62% to -$7.3 million in 2024, then surged by 105.15% to $378000.0 in 2025, then plummeted by 151.85% to -$196000.0 in 2026.
  • Business Quant data shows Non Operating Income for TDOC at -$196000.0 in Q1 2026, $378000.0 in Q4 2025, and -$815000.0 in Q3 2025.